top of page
ATA Posters & Audio
Treatment Utilization Patterns Among Patients Newly Diagnosed with Graves’ Disease: A Real-World Analysis
Lesley-Ann Miller-Wilson,¹ Nicole Princic,² Kristin Evans,² Kylle Tollefsen,¹ David Toro-Tobon³
¹Immunovant, Inc., New York, NY, USA; ²Merative, Ann Arbor, MI, USA; ³Mayo Clinic, Rochester, MN, USA
Incidence and Costs of Adverse Events Following Initiation of Pharmacologic Treatment Used to Manage Graves’ Disease: A Real-World Analysis
Lesley-Ann Miller-Wilson,¹ Nicole Princic,² Kristin Evans,² Kylle Tollefsen,¹ David Toro-Tobon³
¹Immunovant, Inc., New York, NY, USA; ²Merative, Ann Arbor, MI, USA; ³Mayo Clinic, Rochester, MN, USA
bottom of page